Pneumonia

2,952,345views

Pneumonia

Foundations

Foundations

Introduction to the immune system
Innate immune system
Complement system
Contracting the immune response and peripheral tolerance
Cytokines
Monoclonal antibodies
Antibody classes
Bacterial structure and functions
B-cell development
B-cell activation, differentiation, and contraction
T-cell development
T-cell activation
B- and T-cell memory
MHC class I and MHC class II molecules
Thymus histology
Cell cycle
Mitosis and meiosis
DNA replication
DNA damage and repair
DNA mutations
Cell membrane
Free radicals and cellular injury
Hypoxia
Necrosis and apoptosis
Inflammation
Crohn disease
Gout
Gout and pseudogout: Pathology review
Inclusion body myopathy
Inflammatory bowel disease: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Myasthenia gravis
Systemic lupus erythematosus
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Serum sickness
Anaphylaxis
Graft-versus-host disease
Systemic lupus erythematosus (SLE): Pathology review
Pemphigus vulgaris
Stevens-Johnson syndrome
Rheumatic heart disease
Heart failure: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Body fluid compartments
Movement of water between body compartments
Hyponatremia
Pulmonary edema
Lymphedema
Coagulation (secondary hemostasis)
Platelet plug formation (primary hemostasis)
Erythropoietin
Hemophilia
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Blood components
Protein C deficiency
Protein S deficiency
Metaplasia and dysplasia
Multiple endocrine neoplasia: Pathology review
Oncogenes and tumor suppressor genes
Amyloidosis
Atrophy, aplasia, and hypoplasia
Environmental and chemical toxicities: Pathology review
Medication overdoses and toxicities: Pathology review
Multiple endocrine neoplasia
Substance misuse and addiction: Clinical
Toxidromes: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Heparin-induced thrombocytopenia
Myocardial infarction
Shock
Arterial disease
Atherosclerosis and arteriosclerosis: Pathology review
Carbohydrates and sugars
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Fat-soluble vitamin deficiency and toxicity: Pathology review
Folate (Vitamin B9) deficiency
Iron deficiency anemia
Osteomalacia and rickets
Vitamin B12 deficiency
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Wernicke-Korsakoff syndrome
Zinc deficiency and protein-energy malnutrition: Pathology review
Burns: Clinical
Burns
Hyperplasia and hypertrophy
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Klinefelter syndrome
Turner syndrome
Angelman syndrome
Prader-Willi syndrome
Fragile X syndrome
DiGeorge syndrome
Phenylketonuria (NORD)
Homocystinuria
Maple syrup urine disease
Disorders of fatty acid metabolism: Pathology review
Ornithine transcarbamylase deficiency
Post-transplant lymphoproliferative disorders (NORD)
Cytomegalovirus infection after transplant (NORD)
Epigenetics
Gene regulation
Independent assortment of genes and linkage
Inheritance patterns
Mendelian genetics and punnett squares
Evolution and natural selection
Antiphospholipid syndrome
Celiac disease
Graves disease
Multiple sclerosis
Diabetes mellitus
Chronic granulomatous disease
Immunodeficiencies: Clinical
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Candida
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Pneumonia: Pathology review
Pneumonia
Salmonella (non-typhoidal)
Viral structure and functions
Hepatitis medications
Herpesvirus medications
Neuraminidase inhibitors
HIV (AIDS)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Integrase and entry inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Protease inhibitors
Vaccinations: Clinical
The flu vaccine: Information for patients and families
Vaccinations

Transcript

Watch video only

Pneumonia is an infection in the lung tissue caused by microbes, and the result is inflammation.

The inflammation brings water into the lung tissue, and that extra water can make it harder to breathe.

During inhalation, air reaches your lungs by traveling down your trachea, then it continues through the bronchi and the bronchioles and ends up in the alveoli.

The alveoli are tiny air sacs that look like tiny clumps of grapes, that are wrapped up in a net of capillaries. This is where the majority of gas exchange happens in the lungs.

Oxygen leaves the air in the alveoli and crosses into the bloodstream while carbon dioxide leaves the bloodstream and is then exhaled out of the body.

Now, now in addition to air, you’re constantly breathing in other stuff, like microbes. But we’re usually good at protecting ourselves.

For example, we have mechanical techniques like coughing, a mucociliary escalator that lines the entire airway and moves out larger bacteria, and macrophages that are nestled deep inside the alveoli and ready to destroy anything that lands there.

But sometimes, a particularly nasty microbe might succeed in colonizing the bronchioles or alveoli, and when that happens - Congratulations! You’ve got pneumonia.

Those microbes typically multiply and cross over from the airways into the lung tissue, creating an inflammatory response.

The tissue quickly fills with white blood cells as well as proteins, fluid, and even red blood cells if a nearby capillary gets damaged in the process.

Now, there are lots of different pneumonia-causing microbes.

Usually it’s caused by viruses and bacteria, but it can also be caused by fungi and a special class of bacteria called mycobacteria.

In adults, the most common viral cause of pneumonia is influenza, sometimes just called the flu.

In adults, bacterial causes include streptococcus pneumoniae, haemophilus influenzae, and staphylococcus aureus.

There are also more unusual bacteria like mycoplasma pneumoniae, chlamydophila pneumoniae, and legionella pneumophila, which don’t have a cell wall and are well known for causing an “atypical or walking pneumonia” because they often cause vague symptoms like fatigue.

In individuals with a normal immune system, fungi are a rare cause of pneumonia and often it’s regional - for example, there’s Coccidioidomycosis in California and the Southwest - which you can remember because there’s a “C” in both cocci and california, Histoplasmosis in the Ohio and mississippi river valleys - “H” in Histo and in O”H”io, and Blastomycosis which are broad based budding yeast which are in the east - you can remember that with the “east” in yeast.

And the broad based budding refers to the fact that under a microscope, when the fungi bud off of each other there is a broad versus a narrow based.

To round out the fungal causes in the US, there’s Cryptococcus which is “cryptic” because geographically it can pop up really anywhere.

Now, one special fungal culprit is pneumocystis jiroveci which is a risk for immunocompromised individuals.

Finally, there’s mycobacteria which are slow-growing like fungi, hence the “myco” in their name even though they’re still bacteria.

The most well known one is mycobacterium tuberculosis, also just called TB.

Pneumonia can also be categorized by how it’s acquired.

The most common, is community acquired pneumonia, and it’s called that when a person gets sick outside of a hospital or healthcare setting.

Next is hospital-acquired pneumonia or nosocomial pneumonia, which is when a person gets pneumonia when they are already hospitalized for something else.

This type tends to be more serious because sick patients often have a weakened immune systems and the microbes in hospitals are often resistant to the common antibiotics. That’s because hospitals bring together the bacteria that are often the most virulent - think great offense - as well as the most resistant - think great defence.

These bacteria are able to swap some of the antibiotic resistance genes with one another.

A well known example is Methicillin-resistant staphylococcus aureus, or MRSA.

Non resistant staph aureus can cause pneumonia and other infections, but it can also be killed by common antibiotics like ampicillin.

MRSA on the other hand is resistant to many antibiotics and is therefore harder to treat.

Another category of pneumonia is ventilator associated pneumonia, which is a subset of the hospital-acquired pneumonia, but it specifically develops when ill individuals are connected to a ventilator.

Oftentimes, there’s a biofilm - which is a mix of bacteria and sugars and proteins that can coat a surface - that forms on the endotracheal tube.

Individuals on a ventilator can’t cough and are often quite sick already, so over time microbes can move from the tube directly into the lung and cause a pneumonia.

Now in addition to inhaling microbes there are other ways to develop pneumonia.

Key Takeaways

Pneumonia is an infection of the lungs that results in air sacs being filled with fluid. It may be caused by bacteria, viruses, or fungal infections. Pneumonia is either community-acquired, meaning a person got sick outside of a hospital or healthcare setting; or hospital-acquired, which is when a person gets it when they are already hospitalized for something else. Common symptoms of pneumonia can include fever, cough, chest pain, shortness of breath, and difficulty breathing. The severity of symptoms can range from mild to severe. Treatment for pneumonia typically involves drugs to kill the invading pathogen and supportive care such as oxygen therapy.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E (ENHANCED EBOOK)" McGraw Hill Professional (2014)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Pneumonia: update on diagnosis and management" BMJ (2006)
  6. "<i>Streptococcus pneumoniae</i>: Epidemiology, Risk Factors, and Clinical Features" Seminars in Respiratory and Critical Care Medicine (2005)
  7. "Community-acquired pneumonia" The Lancet (2015)
  8. "Intracellular Survival and Replication of &lt;i&gt;Legionella Pneumophila&lt;/i&gt; within Host Cells" YAKUGAKU ZASSHI (2008)
  9. "Epithelial Cells Infected with <i>Chlamydophila pneumoniae</i> ( <i>Chlamydia pneumoniae</i> ) Are Resistant to Apoptosis" Infection and Immunity (2001)